FIELD: medicine.
SUBSTANCE: method involves introduction in a patient's body cyclophosphan, a preparation of a cytostatic group which is introduced in dose 20 to 100 mg/kg of body weight and a preparation of fragmented allogenic two-chained genomic DNA with fragments having a biologically active value and composing a full genome of physiologically and genetically healthy donor (hereinafter - exogenic DNA). The exogenic DNA preparation is introduced 48 hours after each introduction of the cytostatic preparation and for the following 30 days for the scheme when the patient has taken a full course dose 6-14 g, or for the following 3-5 days after a single injection and one day before a following injection with continuing with such intermittent to a complete setting of a therapeutic or supporting dose of the cytostatic preparation.
EFFECT: use of the invention allows higher clinical effectiveness in tumours ensured by differentiated inhibition of cytotoxic and regulatory lymphocyte viability under the effect of cyclophosphan and exogenic DNA.
3 tbl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING STIMULATED DENDRITE CELLS FOR INDUCTION OF IMMUNE RESPONSE AGAINST HUMAN TUBERCULOSIS | 2009 |
|
RU2401664C1 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2010 |
|
RU2489169C2 |
METHOD OF TREATING ONCOLOGICAL DISEASES | 2012 |
|
RU2490028C1 |
METHOD OF CANCER TREATMENT | 2007 |
|
RU2345792C2 |
METHOD FOR ERADICATION OF INITIATING CANCER STEM CELLS | 2013 |
|
RU2542410C1 |
ONCOTHERAPY | 2008 |
|
RU2387456C1 |
METHOD FOR TREATING ONCOLOGICAL DISEASES | 2018 |
|
RU2675233C1 |
METHOD OF TREATING ASCITIC CARCINOMA | 2015 |
|
RU2595864C1 |
METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
PREPARATION ELICITING ANTITUMOR, ANTITOXIC AND RADIOPROTECTING EFFECT | 2003 |
|
RU2234323C1 |
Authors
Dates
2011-09-20—Published
2009-08-03—Filed